360 related articles for article (PubMed ID: 25893403)
1. Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
Yilmaz V; Oflazer P; Aysal F; Durmus H; Poulas K; Yentur SP; Gulsen-Parman Y; Tzartos S; Marx A; Tuzun E; Deymeer F; Saruhan-Direskeneli G
PLoS One; 2015; 10(4):e0123546. PubMed ID: 25893403
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus inhibits Th1 and Th17 responses in MuSK-antibody positive myasthenia gravis patients.
Li Y; Guptill JT; Russo MA; Massey JM; Juel VC; Hobson-Webb LD; Howard JF; Chopra M; Liu W; Yi JS
Exp Neurol; 2019 Feb; 312():43-50. PubMed ID: 30472069
[TBL] [Abstract][Full Text] [Related]
3. CD4
Çebi M; Durmus H; Aysal F; Özkan B; Gül GE; Çakar A; Hocaoglu M; Mercan M; Yentür SP; Tütüncü M; Yayla V; Akan O; Dogan Ö; Parman Y; Saruhan-Direskeneli G
Front Immunol; 2020; 11():809. PubMed ID: 32508812
[TBL] [Abstract][Full Text] [Related]
4. Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.
Yi JS; Guidon A; Sparks S; Osborne R; Juel VC; Massey JM; Sanders DB; Weinhold KJ; Guptill JT
J Autoimmun; 2014 Aug; 52():130-8. PubMed ID: 24378287
[TBL] [Abstract][Full Text] [Related]
5. Roles of cytokines and T cells in the pathogenesis of myasthenia gravis.
Uzawa A; Kuwabara S; Suzuki S; Imai T; Murai H; Ozawa Y; Yasuda M; Nagane Y; Utsugisawa K
Clin Exp Immunol; 2021 Mar; 203(3):366-374. PubMed ID: 33184844
[TBL] [Abstract][Full Text] [Related]
6. Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures.
Farrugia ME; Bonifati DM; Clover L; Cossins J; Beeson D; Vincent A
J Neuroimmunol; 2007 Apr; 185(1-2):136-44. PubMed ID: 17335909
[TBL] [Abstract][Full Text] [Related]
7. Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis.
Ostlie NS; Karachunski PI; Wang W; Monfardini C; Kronenberg M; Conti-Fine BM
J Immunol; 2001 Apr; 166(8):4853-62. PubMed ID: 11290761
[TBL] [Abstract][Full Text] [Related]
8. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
[TBL] [Abstract][Full Text] [Related]
9. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
Cole RN; Reddel SW; Gervásio OL; Phillips WD
Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
Sanadze AG; Sidnev DV; Karganov MIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
[TBL] [Abstract][Full Text] [Related]
11. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.
Nakata R; Motomura M; Masuda T; Shiraishi H; Tokuda M; Fukuda T; Ando T; Yoshimura T; Tsujihata M; Kawakami A
Eur J Neurol; 2013 Sep; 20(9):1272-6. PubMed ID: 23679930
[TBL] [Abstract][Full Text] [Related]
12. [Myasthenia gravis induced by autoantibodies against MuSK].
Shigemoto K; Konishi T; Ohta M
Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
[TBL] [Abstract][Full Text] [Related]
13. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
Vincent A; Leite MI
Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434
[TBL] [Abstract][Full Text] [Related]
14. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G
Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034
[TBL] [Abstract][Full Text] [Related]
15. Effects of Follicular Helper T Cells and Inflammatory Cytokines on Myasthenia Gravis.
Wang L; Zhang Y; Zhu M; Feng J; Han J; Zhu J; Deng H
Curr Mol Med; 2019; 19(10):739-745. PubMed ID: 31453784
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
[TBL] [Abstract][Full Text] [Related]
17. A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression.
Koneczny I; Mané-Damas M; Zong S; De Haas S; Huda S; van Kruining D; Damoiseaux J; De Rosa A; Maestri M; Guida M; Molenaar P; Van Damme P; Fichtenbaum A; Perkmann T; De Baets M; Lazaridis K; Zouvelou V; Tzartos S; Ricciardi R; Losen M; Martinez-Martinez P
Front Immunol; 2024; 15():1325171. PubMed ID: 38715598
[TBL] [Abstract][Full Text] [Related]
18. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
[TBL] [Abstract][Full Text] [Related]
19. IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients.
Koneczny I; Stevens JA; De Rosa A; Huda S; Huijbers MG; Saxena A; Maestri M; Lazaridis K; Zisimopoulou P; Tzartos S; Verschuuren J; van der Maarel SM; van Damme P; De Baets MH; Molenaar PC; Vincent A; Ricciardi R; Martinez-Martinez P; Losen M
J Autoimmun; 2017 Feb; 77():104-115. PubMed ID: 27965060
[TBL] [Abstract][Full Text] [Related]
20. Myasthenia gravis experimentally induced with muscle-specific kinase.
Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
